Clinical Trial Update: Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating Cytotron rotational field quantum nuclear magnetic resonance therapy for multiple sclero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cytotron Rotational Field Quantum Nuclear Magnetic Resonance Therapy (Cytotron RFNMR Therapy)

Snippet

Sponsor: The Centre for Advanced Research & Development, India | Conditions: Multiple Sclerosis | Phase 2 | Status: UNKNOWN